Antibiotic Research UK - Developing New Antibiotics

The charity funds thematic priorities including patient-led research on diagnosis, treatment, and prevention of AMR; awareness campaigns that highlight personal impacts; and policy advocacy to reduce unnecessary antibiotic use. It also supports initiatives such as national patient insight panels and collaborative networks aimed at systemic change. Beneficiaries include patients, families, vulnerable groups facing hospital-acquired infections, and healthcare professionals. Funded projects deliver direct services, evidence dissemination, and behaviour change in clinical practice. The charity works across England, Wales, Scotland, and Northern Ireland, supporting work that has national reach.

Potential partners must be UK-based organisations with demonstrable expertise in antimicrobial resistance and the ability to operate at a national level. While community groups may be eligible, the charity prioritises established bodies such as research networks and advocacy organisations with a track record. Smaller grassroots groups are less likely to be funded. Beneficiaries the charity supports include patients, families, vulnerable groups, and healthcare professionals. The charity seeks partners whose work aligns with its patient-centred approach and thematic priorities.

The charity does not fund basic laboratory research and development, industry-led efforts, or unrestricted core costs. Funding is limited to project-specific work commissioned by the charity.

Funding is strategically commissioned on an invitational basis rather than through open applications. The charity works with established UK-based organisations that have AMR expertise and national reach. Support is provided on a project-specific basis, with opportunities arranged by leadership as needs arise. The charity does not accept unsolicited applications.